Silex Systems Limited is a technology commercialization company, the primary asset of which is the SILEX laser enrichment technology (SILEX technology). It is focused on the commercialization of its SILEX laser-based enrichment technology for application to key global markets: uranium production and enrichment (nuclear power), silicon enrichment (silicon quantum computing) and medical isotope enrichment (new cancer therapies). Its segments include Silex Systems, Translucent and Silex USA. Its technology includes SILEX Laser Isotope Separation Technology, SILEX Uranium Enrichment Technology, Global Laser Enrichment and SILEX Quantum Silicon Production for Quantum Computing. SILEX technology has been under development for uranium enrichment jointly with licensee, Global Laser Enrichment LLC. It is focused on the development of additional commercial applications of SILEX technology, including the production of Quantum Silicon for the emerging technology of silicon-based quantum computing.
Company Information
About this company
Key people
Michael P. Goldsworthy
Chief Executive Officer, Managing Director, Executive Director
Julie E. Russell
Chief Financial Officer, Company Secretary
Craig Andrew Roy
Non-Executive Independent Chairman of the Board
Christopher David Wilks
Non-Executive Director
Susan Jane Corlett
Non-Executive Independent Director
Click to see more
Key facts
- Shares in issue238.11m
- EPICSILXY
- ISINUS8270461036
- LocationAustralia
- SectorTechnology
- IndustrySemiconductors
- Market cap$1.33bn
- Employees38
- ExchangeOver The Counter
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.